XML 78 R67.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Contingencies and commitments (Details) |  |  |  | 84 Months Ended |
--- | --- | --- | --- | --- | ---
Mar. 09, 2018 petition | Mar. 08, 2018 patent | Mar. 05, 2018 lawsuit | Feb. 15, 2018 patent | Mar. 02, 2018 claim
Sanofi/Regeneron Patent Litigation [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Number of pending claims | claim |  |  |  |  | 2
Sensipar (cinacalcet) Patent Litigation [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Gain contingency, number of lawsuits filed | lawsuit |  |  | 4 |  |
Adello NEUPOGEN Patent Litigation [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Gain contingency, patents allegedly infringed upon, number |  | 17 |  |  |
Apotex NEUPOGEN/Neulasta [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Loss contingency, patents allegedly infringed, number |  |  |  | 1 |
Coherus ENBREL Patent Challenge [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Number of denied petitions | petition | 2 |  |  |  |

X
- Definition Gain Contingency, Number of Lawsuits Filed + References No definition available. + Details
Name: | amgn_GainContingencyNumberofLawsuitsFiled
Namespace Prefix: | amgn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of entity's patents that another entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of claims dismissed. + References No definition available. + Details
Name: | us-gaap_LossContingencyClaimsDismissedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_LitigationCaseAxis=amgn_SanofiRegeneronPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=amgn_SensiparcinacalcetPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=amgn_AdelloNEUPOGENPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=amgn_ApotexNEUPOGENNeulastaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=amgn_CoherusENBRELPatentChallengeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |